Skip to main content
Log in

Prophylactic Postoperative High Flow Nasal Oxygen Versus Conventional Oxygen Therapy in Obese Patients Undergoing Bariatric Surgery (OXYBAR Study): a Pilot Randomised Controlled Trial

  • Original Contributions
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Background

Patients with obesity are predisposed to a reduction in end-expiratory lung volume (EELV) and atelectasis after anaesthesia. High flow nasal oxygen (HFNO) may increase EELV, reducing the likelihood of postoperative pulmonary complications (PPC). We conducted a pilot randomised controlled trial (RCT) of conventional oxygen therapy versus HFNO after bariatric surgery. The aim was to investigate the feasibility of using electrical impedance tomography (EIT) as a means of assessing respiratory mechanics and to inform the design of a definitive RCT.

Methods

We performed a single-centre, parallel-group, pilot RCT. Adult patients with obesity undergoing elective bariatric surgery were eligible for inclusion. We excluded patients with a known contraindication to HFNO or with chronic lung disease.

Results

Fifty patients were randomised in equal proportions. One patient crossed over from conventional O2 to HFNO. Delta EELI was higher at 1 hour in patients receiving HFNO (mean difference = 831 Au (95% CI − 1636–3298), p = 0.5). Continuous EIT beyond 1 hour was poorly tolerated. At 6 hours, there were no differences in PaO2/FiO2 ratio or PaCO2. Only one patient developed a PPC (in the HFNO group) by 6 weeks.

Conclusions

These data suggest that a large-scale RCT of HFNO after bariatric surgery in an ‘all-comers’ population is likely infeasible. While EIT was an effective means of assessing respiratory mechanics, it was impractical over time. Similarly, the infrequency of PPC precludes its use as a primary outcome. Future studies should focus on identifying patients at the greatest risk of PPC.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (London, England). 2014;384(9945):766–81.

    Article  Google Scholar 

  2. Angrisani L, Santonicola A, Iovino P, et al. IFSO Worldwide Survey 2016: primary, endoluminal, and revisional procedures. Obes Surg. 2018;28(12):3783–94.

    Article  Google Scholar 

  3. Welbourn R, Hollyman M, Kinsman R, et al. Bariatric surgery worldwide: baseline demographic description and one-year outcomes from the fourth IFSO Global Registry Report 2018. Obes Surg. 2019;29(3):782–95.

    Article  Google Scholar 

  4. Bamgbade OA, Rutter TW, Nafiu OO, et al. Postoperative complications in obese and nonobese patients. World J Surg. 2007;31(3):556–60 (discussion 561).

    Article  Google Scholar 

  5. Littleton SW, Tulaimat A. The effects of obesity on lung volumes and oxygenation. Respir Med. 2017;124:15–20.

    Article  Google Scholar 

  6. Oppenheimer BW, Berger KI, Segal LN, et al. Airway dysfunction in obesity: response to voluntary restoration of end expiratory lung volume. PloS One. 2014;9(2):e88015.

    Article  CAS  Google Scholar 

  7. Parameswaran K, Todd DC, Soth M. Altered respiratory physiology in obesity. Can Respir J. 2006;13(4):203–10.

    Article  Google Scholar 

  8. Rivas E, Arismendi E, Agustí A, et al. Ventilation/perfusion distribution abnormalities in morbidly obese subjects before and after bariatric surgery. Chest. 2015;147(4):1127–34.

    Article  Google Scholar 

  9. Baltieri L, Peixoto-Souza FS, Rasera-Junior I, et al. Analysis of the prevalence of atelectasis in patients undergoing bariatric surgery. Rev Bras Anestesiol. 2016;66(6):577–82.

    Article  Google Scholar 

  10. Benoist S, Panis Y, Alves A, et al. Impact of obesity on surgical outcomes after colorectal resection. Am J Surg. 2000;179(4):275–81.

    Article  CAS  Google Scholar 

  11. Merkow RP, Bilimoria KY, McCarter MD, et al. Effect of body mass index on short-term outcomes after colectomy for cancer. J Am Coll Surg. 2009;208(1):53–61.

    Article  Google Scholar 

  12. Mullen JT, Davenport DL, Hutter MM, et al. Impact of body mass index on perioperative outcomes in patients undergoing major intra-abdominal cancer surgery. Ann Surg Oncol. 2008;15(8):2164–72.

    Article  Google Scholar 

  13. Ashraf-Kashani N, Kumar R. High-flow nasal oxygen therapy. BJA Education. 2017;17(2):57–62.

    Article  Google Scholar 

  14. Corley A, Caruana LR, Barnett AG, et al. Oxygen delivery through high-flow nasal cannulae increase end-expiratory lung volume and reduce respiratory rate in post-cardiac surgical patients. Br J Anaesth. 2011;107(6):998–1004.

    Article  CAS  Google Scholar 

  15. Thabane L, Hopewell S, Lancaster GA, et al. Methods and processes for development of a CONSORT extension for reporting pilot randomized controlled trials. Pilot Feas Stud. 2016;2(1):25.

    Article  Google Scholar 

  16. Fulton R, Millar JE, Merza M, et al. High flow nasal oxygen after bariatric surgery (OXYBAR), prophylactic post-operative high flow nasal oxygen versus conventional oxygen therapy in obese patients undergoing bariatric surgery: study protocol for a randomised controlled pilot trial. Trials. 2018;19(1):402.

    Article  Google Scholar 

  17. Mauri T, Turrini C, Eronia N, et al. Physiologic effects of high-flow nasal cannula in acute hypoxemic respiratory failure. Am J Respir Crit Care Med. 2017;195(9):1207–15.

    Article  Google Scholar 

  18. Riera J, Pérez P, Cortés J, et al. Effect of high-flow nasal cannula and body position on end-expiratory lung volume: a cohort study using electrical impedance tomography. Respir Care. 2013;58(4):589–96.

    Article  Google Scholar 

  19. Borg G. Borg’s perceived exertion and pain scales. Champaign, IL: Human Kinetics, 1998.

  20. Zhang R, He H, Yun L, et al. Effect of postextubation high-flow nasal cannula therapy on lung recruitment and overdistension in high-risk patient. Crit Care. 2020;24(1):82.

    Article  Google Scholar 

  21. Yu Y, Qian X, Liu C, et al. Effect of high-flow nasal cannula versus conventional oxygen therapy for patients with thoracoscopic lobectomy after extubation. Can Respir J. 2017;2017:7894631.

    Article  Google Scholar 

  22. BodurYildirim F, Öcal S, ErsoyOrtac E, et al. High flow nasal oxygen therapy usage in the adult intensive care units in Turkey: multi-center, prospective study. Eur Res J. 2019;54(suppl 63):PA4020.

    Google Scholar 

  23. Lu Z, Chang W, Meng S-S, et al. Effect of high-flow nasal cannula oxygen therapy compared with conventional oxygen therapy in postoperative patients: a systematic review and meta-analysis. BMJ Open. 2019;9(8):e027523.

    Article  Google Scholar 

  24. Kelkar KV. Post-operative pulmonary complications after non-cardiothoracic surgery. Indian J Anaesth. 2015;59(9):599–605.

    Article  Google Scholar 

  25. Gupta PK, Gupta H, Kaushik M, et al. Predictors of pulmonary complications after bariatric surgery. Surg Obes Relat Dis. 2012;8(5):574–81.

    Article  Google Scholar 

Download references

Funding

The study was funded by Wesley Medical Research (Australia).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John F. Fraser.

Ethics declarations

Conflict of Interest

The study received grant funding from Wesley Medical Research (Australia). The corresponding author has received travel and research support from Fisher & Paykel Pty Ltd. Rachel Fulton has no conflict of interest. Jonathan Millar has received honoraria from Fisher & Paykel Pty Ltd for an educational activity. Megan Merza and Helen Johnston have no conflict of interest. Amanda Corley has received honoraria from Fisher & Paykel Pty Ltd for an educational activity. Daniel Faulke, Ivan Rapchuk, Joe Tarpey, Jonathon Fanning, Philip Lockie, and Shirley Lockie have no conflict of interest. John Fraser has received honoraria from Fisher & Paykel Ltd. For educational activity and research support unrelated to this study. Fisher & Paykel Pty Ltd were not involved in the conception, design, or analysis of this study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Key Points

• HFNO failed to produce a significant increase in EELI at 60 min.

• The use of HFNO was not associated with improvements in PaO2/FiO2 ratio, dyspnoea, length of stay, or the incidence of postoperative pulmonary complications. However, the incidence of PPC was low.

• The use of HFNO was associated with higher pain scores at 6 hours.

• Based on these data, a large-scale RCT of HFNO after bariatric surgery in an ‘all-comers’ population is likely infeasible.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fulton, R., Millar, J.E., Merza, M. et al. Prophylactic Postoperative High Flow Nasal Oxygen Versus Conventional Oxygen Therapy in Obese Patients Undergoing Bariatric Surgery (OXYBAR Study): a Pilot Randomised Controlled Trial. OBES SURG 31, 4799–4807 (2021). https://doi.org/10.1007/s11695-021-05644-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-021-05644-y

Keywords

Navigation